Granite Point Capital Management, L.P. Icad Inc Transaction History

Granite Point Capital Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$3.02 - $4.56 $383,111 - $578,472	-126,858 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$3.92 - $7.48 $203,283 - $387,897	51,858 Added 69.14%	126,858 $566,000
Q4 2021 Feb 11, 2022	SELL	$6.7 - $11.38 $740,169 - $1.26 Million	-110,473 Reduced 59.56%	75,000 $540,000
Q3 2021 Nov 10, 2021	SELL	$10.11 - $17.56 $202,200 - $351,200	-20,000 Reduced 9.73%	185,473 $1.99 Million
Q2 2021 Aug 16, 2021	BUY	$14.9 - $20.82 $1.49 Million - $2.08 Million	100,000 Added 94.81%	205,473 $3.56 Million
Q1 2021 May 12, 2021	SELL	$12.57 - $21.22 $918,841 - $1.55 Million	-73,098 Reduced 40.93%	105,473 $2.24 Million
Q4 2020 Feb 05, 2021	BUY	$8.73 - $14.56 $1.56 Million - $2.6 Million	178,571 New	178,571 $2.36 Million

5.39M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $61.3M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.